Skip to main content
NCBI home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 1997 Apr-Jun;3(2):113–127. doi: 10.3201/eid0302.970204

Polycystic kidney disease: an unrecognized emerging infectious disease?

M A Miller-Hjelle 1, J T Hjelle 1, M Jones 1, W R Mayberry 1, M A Dombrink-Kurtzman 1, S W Peterson 1, D M Nowak 1, F S Darras 1
PMCID: PMC2627604  PMID: 9204292

Abstract

Polycystic kidney disease (PKD) is one of the most common genetic diseases in humans. We contend that it may be an emerging infectious disease and/or microbial toxicosis in a vulnerable human subpopulation. Use of a differential activation protocol for the Limulus amebocyte lysate (LAL) assay showed bacterial endotoxin and fungal (1-->3)-beta-D-glucans in cyst fluids from human kidneys with PKD. Fatty acid analysis of cyst fluid confirmed the presence of 3-hydroxy fatty acids characteristic of endotoxin. Tissue and cyst fluid from three PKD patients were examined for fungal components. Serologic tests showed Fusarium, Aspergillus, and Candida antigens. IgE, but not IgG, reactive with Fusarium and Candida were also detected in cyst fluid. Fungal DNA was detected in kidney tissue and cyst fluid from these three PKD patients, but not in healthy human kidney tissue. We examine the intertwined nature of the actions of endotoxin and fungal components, sphingolipid biology in PKD, the structure of PKD gene products, infections, and integrity of gut function to establish a mechanistic hypothesis for microbial provocation of human cystic disease. Proof of this hypothesis will require identification of the microbes and microbial components involved and multifaceted studies of PKD cell biology.

Full Text

The Full Text of this article is available as a PDF (375.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ballou L. R., Laulederkind S. J., Rosloniec E. F., Raghow R. Ceramide signalling and the immune response. Biochim Biophys Acta. 1996 Jun 11;1301(3):273–287. doi: 10.1016/0005-2760(96)00004-5. [DOI] [PubMed] [Google Scholar]
  2. Barber S. A., Detore G., McNally R., Vogel S. N. Stimulation of the ceramide pathway partially mimics lipopolysaccharide-induced responses in murine peritoneal macrophages. Infect Immun. 1996 Aug;64(8):3397–3400. doi: 10.1128/iai.64.8.3397-3400.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bibel D. J., Aly R., Shah S., Shinefield H. R. Sphingosines: antimicrobial barriers of the skin. Acta Derm Venereol. 1993 Dec;73(6):407–411. doi: 10.2340/0001555573407411. [DOI] [PubMed] [Google Scholar]
  4. Calvet J. P. Injury and development in polycystic kidney disease. Curr Opin Nephrol Hypertens. 1994 May;3(3):340–348. doi: 10.1097/00041552-199405000-00017. [DOI] [PubMed] [Google Scholar]
  5. Carone F. A., Bacallao R., Kanwar Y. S. The pathogenesis of polycystic kidney disease. Histol Histopathol. 1995 Jan;10(1):213–221. [PubMed] [Google Scholar]
  6. Cook J. A., Dougherty W. J., Holt T. M. Enhanced sensitivity to endotoxin induced by the RE stimulant, glucan. Circ Shock. 1980;7(3):225–238. [PubMed] [Google Scholar]
  7. Counts R. S., Nowak G., Wyatt R. D., Schnellmann R. G. Nephrotoxicant inhibition of renal proximal tubule cell regeneration. Am J Physiol. 1995 Aug;269(2 Pt 2):F274–F281. doi: 10.1152/ajprenal.1995.269.2.F274. [DOI] [PubMed] [Google Scholar]
  8. Deitch E. A., Berg R., Specian R. Endotoxin promotes the translocation of bacteria from the gut. Arch Surg. 1987 Feb;122(2):185–190. doi: 10.1001/archsurg.1987.01400140067008. [DOI] [PubMed] [Google Scholar]
  9. Deshmukh G. D., Radin N. S., Gattone V. H., 2nd, Shayman J. A. Abnormalities of glycosphingolipid, sulfatide, and ceramide in the polycystic (cpk/cpk) mouse. J Lipid Res. 1994 Sep;35(9):1611–1618. [PubMed] [Google Scholar]
  10. Douwes J., Doekes G., Montijn R., Heederik D., Brunekreef B. Measurement of beta(1-->3)-glucans in occupational and home environments with an inhibition enzyme immunoassay. Appl Environ Microbiol. 1996 Sep;62(9):3176–3182. doi: 10.1128/aem.62.9.3176-3182.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fredricks D. N., Relman D. A. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin Microbiol Rev. 1996 Jan;9(1):18–33. doi: 10.1128/cmr.9.1.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gans H., Matsumoto K. The escape of endotoxin from the intestine. Surg Gynecol Obstet. 1974 Sep;139(3):395–402. [PubMed] [Google Scholar]
  13. Gardner K. D., Jr, Burnside J. S., Elzinga L. W., Locksley R. M. Cytokines in fluids from polycystic kidneys. Kidney Int. 1991 Apr;39(4):718–724. doi: 10.1038/ki.1991.87. [DOI] [PubMed] [Google Scholar]
  14. Gardner K. D., Jr, Evan A. P., Reed W. P. Accelerated renal cyst development in deconditioned germ-free rats. Kidney Int. 1986 Jun;29(6):1116–1123. doi: 10.1038/ki.1986.116. [DOI] [PubMed] [Google Scholar]
  15. Gardner K. D., Jr, Glew R. H., Evan A. P., McAteer J. A., Bernstein J. Why renal cysts grow. Am J Physiol. 1994 Mar;266(3 Pt 2):F353–F359. doi: 10.1152/ajprenal.1994.266.3.F353. [DOI] [PubMed] [Google Scholar]
  16. Gardner K. D., Jr, Reed W. P., Evan A. P., Zedalis J., Hylarides M. D., Leon A. A. Endotoxin provocation of experimental renal cystic disease. Kidney Int. 1987 Sep;32(3):329–334. doi: 10.1038/ki.1987.213. [DOI] [PubMed] [Google Scholar]
  17. Garner R. E., Hudson J. A. Intravenous injection of Candida-derived mannan results in elevated tumor necrosis factor alpha levels in serum. Infect Immun. 1996 Nov;64(11):4561–4566. doi: 10.1128/iai.64.11.4561-4566.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gelderblom W. C., Kriek N. P., Marasas W. F., Thiel P. G. Toxicity and carcinogenicity of the Fusarium moniliforme metabolite, fumonisin B1, in rats. Carcinogenesis. 1991 Jul;12(7):1247–1251. doi: 10.1093/carcin/12.7.1247. [DOI] [PubMed] [Google Scholar]
  19. Grantham J. J. Acquired cystic kidney disease. Kidney Int. 1991 Jul;40(1):143–152. doi: 10.1038/ki.1991.192. [DOI] [PubMed] [Google Scholar]
  20. Grantham J. J. The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: recent advances. Am J Kidney Dis. 1996 Dec;28(6):788–803. doi: 10.1016/s0272-6386(96)90378-9. [DOI] [PubMed] [Google Scholar]
  21. Han J., Lee J. D., Bibbs L., Ulevitch R. J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 1994 Aug 5;265(5173):808–811. doi: 10.1126/science.7914033. [DOI] [PubMed] [Google Scholar]
  22. Hannun Y. A. Functions of ceramide in coordinating cellular responses to stress. Science. 1996 Dec 13;274(5294):1855–1859. doi: 10.1126/science.274.5294.1855. [DOI] [PubMed] [Google Scholar]
  23. Huang C., Dickman M., Henderson G., Jones C. Repression of protein kinase C and stimulation of cyclic AMP response elements by fumonisin, a fungal encoded toxin which is a carcinogen. Cancer Res. 1995 Apr 15;55(8):1655–1659. [PubMed] [Google Scholar]
  24. Ikemura K., Ikegami K., Shimazu T., Yoshioka T., Sugimoto T. False-positive result in Limulus test caused by Limulus amebocyte lysate-reactive material in immunoglobulin products. J Clin Microbiol. 1989 Sep;27(9):1965–1968. doi: 10.1128/jcm.27.9.1965-1968.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Iwata M., Herrington J., Zager R. A. Sphingosine: a mediator of acute renal tubular injury and subsequent cytoresistance. Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8970–8974. doi: 10.1073/pnas.92.19.8970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  27. Latgé J. P., Kobayashi H., Debeaupuis J. P., Diaquin M., Sarfati J., Wieruszeski J. M., Parra E., Bouchara J. P., Fournet B. Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus. Infect Immun. 1994 Dec;62(12):5424–5433. doi: 10.1128/iai.62.12.5424-5433.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Levi M. E., Eshaghi N., Smith J. W., Elkind C. Fever of unknown origin following an upper gastrointestinal series in a patient with polycystic kidney disease. South Med J. 1995 Jul;88(7):769–770. doi: 10.1097/00007611-199507000-00017. [DOI] [PubMed] [Google Scholar]
  29. Lim C. W., Parker H. M., Vesonder R. F., Haschek W. M. Intravenous fumonisin B1 induces cell proliferation and apoptosis in the rat. Nat Toxins. 1996;4(1):34–41. doi: 10.1002/19960401nt5. [DOI] [PubMed] [Google Scholar]
  30. Malhotra R. Collectin receptor (C1q receptor): structure and function. Behring Inst Mitt. 1993 Dec;(93):254–261. [PubMed] [Google Scholar]
  31. Martinez J. R., Grantham J. J. Polycystic kidney disease: etiology, pathogenesis, and treatment. Dis Mon. 1995 Nov;41(11):693–765. doi: 10.1016/s0011-5029(05)80007-0. [DOI] [PubMed] [Google Scholar]
  32. Martinova E. A., Merrill A. H., Jr Fumonisin B1 alters sphingolipid metabolism and immune function in BALB/c mice: immunological responses to fumonisin B1. Mycopathologia. 1995 Jun;130(3):163–170. doi: 10.1007/BF01103100. [DOI] [PubMed] [Google Scholar]
  33. Mays R. W., Siemers K. A., Fritz B. A., Lowe A. W., van Meer G., Nelson W. J. Hierarchy of mechanisms involved in generating Na/K-ATPase polarity in MDCK epithelial cells. J Cell Biol. 1995 Sep;130(5):1105–1115. doi: 10.1083/jcb.130.5.1105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Merrill A. H., Jr, Liotta D. C., Riley R. T. Fumonisins: fungal toxins that shed light on sphingolipid function. Trends Cell Biol. 1996 Jun;6(6):218–223. doi: 10.1016/0962-8924(96)10021-0. [DOI] [PubMed] [Google Scholar]
  35. Miller M. A., Prior R. B., Horvath F. J., Hjelle J. T. Detection of endotoxiuria in polycystic kidney disease patients by the use of the Limulus amebocyte lysate assay. Am J Kidney Dis. 1990 Feb;15(2):117–122. doi: 10.1016/s0272-6386(12)80508-7. [DOI] [PubMed] [Google Scholar]
  36. Miyazaki T., Kohno S., Mitsutake K., Maesaki S., Tanaka K., Hara K. (1-->3)-beta-D-glucan in culture fluid of fungi activates factor G, a limulus coagulation factor. J Clin Lab Anal. 1995;9(5):334–339. doi: 10.1002/jcla.1860090509. [DOI] [PubMed] [Google Scholar]
  37. Mochizuki T., Wu G., Hayashi T., Xenophontos S. L., Veldhuisen B., Saris J. J., Reynolds D. M., Cai Y., Gabow P. A., Pierides A. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science. 1996 May 31;272(5266):1339–1342. doi: 10.1126/science.272.5266.1339. [DOI] [PubMed] [Google Scholar]
  38. Moy G. W., Mendoza L. M., Schulz J. R., Swanson W. J., Glabe C. G., Vacquier V. D. The sea urchin sperm receptor for egg jelly is a modular protein with extensive homology to the human polycystic kidney disease protein, PKD1. J Cell Biol. 1996 May;133(4):809–817. doi: 10.1083/jcb.133.4.809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Muhlestein J. B., Hammond E. H., Carlquist J. F., Radicke E., Thomson M. J., Karagounis L. A., Woods M. L., Anderson J. L. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol. 1996 Jun;27(7):1555–1561. doi: 10.1016/0735-1097(96)00055-1. [DOI] [PubMed] [Google Scholar]
  40. Munford R. S., Hall C. L., Lipton J. M., Dietschy J. M. Biological activity, lipoprotein-binding behavior, and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides. J Clin Invest. 1982 Oct;70(4):877–888. doi: 10.1172/JCI110684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Nolan J. P. Intestinal endotoxins as mediators of hepatic injury--an idea whose time has come again. Hepatology. 1989 Nov;10(5):887–891. doi: 10.1002/hep.1840100523. [DOI] [PubMed] [Google Scholar]
  42. Notermans S., Dufrenne J., Wijnands L. M., Engel H. W. Human serum antibodies to extracellular polysaccharides (EPS) of moulds. J Med Vet Mycol. 1988 Feb;26(1):41–48. doi: 10.1080/02681218880000051. [DOI] [PubMed] [Google Scholar]
  43. Obayashi T., Tamura H., Tanaka S., Ohki M., Takahashi S., Kawai T. Endotoxin-inactivating activity in normal and pathological human blood samples. Infect Immun. 1986 Aug;53(2):294–297. doi: 10.1128/iai.53.2.294-297.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Pörtner A., Peter-Katalinić J., Brade H., Unland F., Büntemeyer H., Müthing J. Structural characterization of gangliosides from resting and endotoxin-stimulated murine B lymphocytes. Biochemistry. 1993 Nov 30;32(47):12685–12693. doi: 10.1021/bi00210a018. [DOI] [PubMed] [Google Scholar]
  45. Raetz C. R., Ulevitch R. J., Wright S. D., Sibley C. H., Ding A., Nathan C. F. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J. 1991 Sep;5(12):2652–2660. doi: 10.1096/fasebj.5.12.1916089. [DOI] [PubMed] [Google Scholar]
  46. Reed J. C. Bcl-2 and the regulation of programmed cell death. J Cell Biol. 1994 Jan;124(1-2):1–6. doi: 10.1083/jcb.124.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Rietschel E. T., Kirikae T., Schade F. U., Mamat U., Schmidt G., Loppnow H., Ulmer A. J., Zähringer U., Seydel U., Di Padova F. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 1994 Feb;8(2):217–225. doi: 10.1096/fasebj.8.2.8119492. [DOI] [PubMed] [Google Scholar]
  48. Riley R. T., Wang E., Schroeder J. J., Smith E. R., Plattner R. D., Abbas H., Yoo H. S., Merrill A. H., Jr Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins. Nat Toxins. 1996;4(1):3–15. doi: 10.1002/19960401nt2. [DOI] [PubMed] [Google Scholar]
  49. Roby R. R., Sneller M. R. Incidence of fungal spores at the homes of allergic patients in an agricultural community. II. Correlations of skin tests with mold frequency. Ann Allergy. 1979 Nov;43(5):286–288. [PubMed] [Google Scholar]
  50. Scheff R. T., Zuckerman G., Harter H., Delmez J., Koehler R. Diverticular disease in patients with chronic renal failure due to polycystic kidney disease. Ann Intern Med. 1980 Feb;92(2 Pt 1):202–204. doi: 10.7326/0003-4819-92-2-202. [DOI] [PubMed] [Google Scholar]
  51. Schwab S. J., Bander S. J., Klahr S. Renal infection in autosomal dominant polycystic kidney disease. Am J Med. 1987 Apr;82(4):714–718. doi: 10.1016/0002-9343(87)90005-2. [DOI] [PubMed] [Google Scholar]
  52. Shayman J. A., Radin N. S. Structure and function of renal glycosphingolipids. Am J Physiol. 1991 Mar;260(3 Pt 2):F291–F302. doi: 10.1152/ajprenal.1991.260.3.F291. [DOI] [PubMed] [Google Scholar]
  53. Shayman J. A. Sphingolipids: their role in intracellular signaling and renal growth. J Am Soc Nephrol. 1996 Feb;7(2):171–182. doi: 10.1681/ASN.V72171. [DOI] [PubMed] [Google Scholar]
  54. Sklar A. H., Caruana R. J., Lammers J. E., Strauser G. D. Renal infections in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1987 Aug;10(2):81–88. doi: 10.1016/s0272-6386(87)80036-7. [DOI] [PubMed] [Google Scholar]
  55. Spiegel S., Merrill A. H., Jr Sphingolipid metabolism and cell growth regulation. FASEB J. 1996 Oct;10(12):1388–1397. doi: 10.1096/fasebj.10.12.8903509. [DOI] [PubMed] [Google Scholar]
  56. Sturk A., van Deventer S. J., Wortel C. H., Levels J. H., ten Cate J. W., Büller H. R., Sanders G. T. Detection and clinical relevance of human endotoxemia. Z Med Lab Diagn. 1990;31(3):147–158. [PubMed] [Google Scholar]
  57. Veis D. J., Sorenson C. M., Shutter J. R., Korsmeyer S. J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell. 1993 Oct 22;75(2):229–240. doi: 10.1016/0092-8674(93)80065-m. [DOI] [PubMed] [Google Scholar]
  58. Wang W., Jones C., Ciacci-Zanella J., Holt T., Gilchrist D. G., Dickman M. B. Fumonisins and Alternaria alternata lycopersici toxins: sphinganine analog mycotoxins induce apoptosis in monkey kidney cells. Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3461–3465. doi: 10.1073/pnas.93.8.3461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Werder A. A., Amos M. A., Nielsen A. H., Wolfe G. H. Comparative effects of germfree and ambient environments on the development of cystic kidney disease in CFWwd mice. J Lab Clin Med. 1984 Mar;103(3):399–407. [PubMed] [Google Scholar]
  60. Wilkinson M. F., Earle M. L., Triggle C. R., Barnes S. Interleukin-1beta, tumor necrosis factor-alpha, and LPS enhance calcium channel current in isolated vascular smooth muscle cells of rat tail artery. FASEB J. 1996 May;10(7):785–791. doi: 10.1096/fasebj.10.7.8635696. [DOI] [PubMed] [Google Scholar]
  61. Winyard P. J., Nauta J., Lirenman D. S., Hardman P., Sams V. R., Risdon R. A., Woolf A. S. Deregulation of cell survival in cystic and dysplastic renal development. Kidney Int. 1996 Jan;49(1):135–146. doi: 10.1038/ki.1996.18. [DOI] [PubMed] [Google Scholar]
  62. Woo D. Apoptosis and loss of renal tissue in polycystic kidney diseases. N Engl J Med. 1995 Jul 6;333(1):18–25. doi: 10.1056/NEJM199507063330104. [DOI] [PubMed] [Google Scholar]
  63. Wright S. D., Kolesnick R. N. Does endotoxin stimulate cells by mimicking ceramide? Immunol Today. 1995 Jun;16(6):297–302. doi: 10.1016/0167-5699(95)80185-5. [DOI] [PubMed] [Google Scholar]
  64. Yoshida M., Roth R. I., Grunfeld C., Feingold K. R., Levin J. Soluble (1-->3)-beta-D-glucan purified from Candida albicans: biologic effects and distribution in blood and organs in rabbits. J Lab Clin Med. 1996 Jul;128(1):103–114. doi: 10.1016/s0022-2143(96)90119-5. [DOI] [PubMed] [Google Scholar]
  65. Zhang G. H., Baek L., Buchardt O., Koch C. Differential blocking of coagulation-activating pathways of Limulus amebocyte lysate. J Clin Microbiol. 1994 Jun;32(6):1537–1541. doi: 10.1128/jcm.32.6.1537-1541.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES